EZH2 and non-small cell lung carcinoma: In EZH2-knockdown NSCLC cells, which display reduced metastatic potential and decreased levels of EMT markers, the inhibition of SPRY4-IT1 could partially restore invasiveness and reverse the downregulation of EMT markers.